Dataset
Clonidine; LC-ESI-QTOF; MS2; CE: 30 eV; R=35000; [M+H]+
Chemical Information
| InChI | InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14) |
|---|---|
| SMILES | ClC1=CC=CC(Cl)=C1NC1=NCCN1 |
| InChI Key | GJSURZIOUXUGAL-UHFFFAOYSA-N |
| Molecular Formula | C9H9Cl2N3 |
| Exact Mass | 229.017 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU272003 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2019-05-30 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| DTXSID6022846 | EPA CompTox Dashboard |
| 50016897 | BindingDB |
| MUFBUK | CCDC |
| J9.618K | Nikkaji |
| 704 | DrugCentral |
| HY-12721 | MedChemExpress |
| CLONIDINE HYDROCHLORIDE | clinicaltrials |
| CLONIDINE | clinicaltrials |
| DURACLON | clinicaltrials |
| ST-155 | clinicaltrials |
| KAPVAY | clinicaltrials |
| JENLOGA | clinicaltrials |
| CLORPRES | rxnorm |
| DURACLON | rxnorm |
| KAPVAY | rxnorm |
| CLONIDINE HYDROCHLORIDE | rxnorm |
| CLONIDINE | rxnorm |
| CATAPRES | rxnorm |
| CLONIDINE | DailyMed |
| 14062 | BindingDB |
| 50225285 | BindingDB |
| DB00575 | DrugBank |
| CLU | PDBe |
| CHEMBL134 | ChEMBL |
| 3757 | ChEBI |
| 46632 | ChEBI |
| 516 | Guide to Pharmacology |
| MCULE-5017779690 | Mcule |
| ZINC000000896484 | ZINC |
| CB6505769 | ChemicalBook |
| clonidine | DailyMed |
| HMDB0014714 | Human Metabolome Database |
| 13274 | Brenda |
| 2803 | PubChem |
| PD009910 | ProbesDrugs |
| MN3L5RMN02 | FDA SRS |
| LSM-4223 | LINCS |
| 14822899 | PubChem: Thomson Pharma |
| SCHEMBL5982 | SureChEMBL |
| PA449051 | PharmGKB |
| 15172366 | PubChem: Thomson Pharma |
| 4205-90-7 | ACToR |
| 969274 | eMolecules |
| The data in this table is sourced from UniChem at EBI. | |